1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. EQUILLIUM INC
Equillium Inc
XNAS: EQ
Download real time
1.39-0.03(-2.11%)
60.73% Fall from 52W High
343.3K
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Equillium Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Equillium Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Equillium Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Equillium Inc Jun-2026 Quarterly Net Profit is $-5 Million which is growth of 18.2% YoY.

Equillium Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
4.412.213.910.79.28.99.1
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
5.25.644.66.28.99.112.81413.512.412.512.7
Operating Profit
-5.2-5.6-4-4.6-6.2-8.9-4.7-0.7-0.1-2.8-3.2-3.6-3.6
⌄
0.50.30.30.20.10.20.20.30.40.40.50.60.4
Profit Before Tax
-4.7-5.3-3.8-4.2-5.7-8.7-5.4-00.5-2.7-2.3-3.2-3.3
Tax
------0.400.50
⌄
-4.7-5.3-3.8-4.2-5.7-8.7-5.8-00.5-2.7-2.3-3.7-3.3
Diluted NI Avail to Com Stockholders Ann.
-4.7-5.3-3.8-4.2-5.7-8.7-5.8-00.5-2.7-2.3-3.7-3.3
Basic EPS
-0-0.1-0-0.1-0.2-0.2-0.20-0.1-0.1-0.1-0.1
Diluted EPS After ExtraOrdinary
-0-0.1-0-0.1-0.2-0.2-0.20-0.1-0.1-0.1-0.1
Number Of Shares End
111.896.361.565.335.735.635.535.435.335.335.234.934.5
Net Income Continuing Discontinued Operations
-4.7-5.3-3.8-4.2-5.7-8.7-5.8-00.5-2.7-2.3-3.7-3.3
Normalized Income
-4.7-5.3-3.8-4.2-5.7-8.7-5.8-00.5-2.7-2.3-3.7-3.3
Interest Income
0.50.30.30.20.10.20.20.30.40.40.50.60.6
Interest
------0.3
Net Interest Income
0.50.30.30.20.10.20.20.30.40.40.50.60.4
EBIT
-5.2-5.6-4-4.6-6.2-8.9-5.4-00.5-2.7-2.3-3.2-3.1
EBITDA
-5.1-5.6-3.9-4.6-6.2-8.8-5.400.5-2.7-2.3-3.2-3
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
0000000000000
Profit From Continuing Operations
-4.7-5.3-3.8-4.2-5.7-8.7-5.8-00.5-2.7-2.3-3.7-3.3
Normalized EBITDA
-5.1-5.6-3.9-4.6-6.2-8.8-5.400.5-2.7-2.3-3.2-3
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Equillium Inc competitor comparison and performance snapshot within industry

Equillium Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Equillium Inc Annual Revenue is $0 Million which is growth of -100.0% YoY.

  • NEGATIVE

    Annual Net Profit Equillium Inc Annual Net Profit is $-22 Million which is growth of -177.6% YoY.

Equillium Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-
-
 41.136.115.8-
Cost Of Rev. Ann.
-
-
 ---------
Gross Profit Ann.
-
-
 ---------
Operating Exp. Ann.
-24.5%
-4.4%
19.323.649.450.654.837.829.626.78.6
Operating Profit Ann.
-
-
-19.3-23.6-8.3-14.5-39-37.8-29.6-26.7-8.6
⌄
-
-
1.40.81.41.8-0.6-1-0.61.1-2.2-
Other Exp. Ann.
-
0%
 0.4-0.8-0.1-22.8-0.30.40-2.4-
PBT Ann.
-
-
-18-22.4-7.7-12.8-62.4-39.1-29.8-25.6-13.3-
Tax Ann.
-
-
 0.40.6------
⌄
-
-
-18-22.4-8.1-13.3-62.4-39.1-29.8-25.6-13.3-
Diluted NI Avail to Com Stockholders Ann.
-
-
-18-22.4-8.1-13.3-62.4-39.1-29.8-25.6-13.3-
EPS Ann.
-
-
 -0.4-0.2-0.4-1.9-1.4-1.5-1.5-1.1-
Diluted EPS Ann.
-
-
 -0.4-0.2-0.4-1.9-1.4-1.5-1.5-1.1-
Number Of Shares End
21.4%
19.9%
 61.535.535.234.429.424.817.417.411.7
Total Exp. Ann.
-24.5%
-4.4%
 23.649.450.654.837.829.626.78.6-
Net Income Continuing Discontinued Operations Ann.
-
-
-18-22.4-8.1-13.3-62.4-39.1-29.8-25.6-13.3-
Normalized Income Ann.
-
-
-18-22.4-8.1-13.3-39.4-39.1-29.8-25.6-13.3-
Interest Income Ann.
26%
9.9%
1.40.81.42.30.40.10.51.40.3-
Interest Ann.
-
-
 -0.51.11.11.10.32.6-
EBITDA Ann.
-
-
-19.2-23.5-7.6-12.1-61.3-37.9-28.7-25.3-10.7-
Reconciled Cost Of Rev. Ann.
-
-
 ---------
Reconciled Depr. Ann.
0%
-
0.10.10.10.10.10.1000-
Profit From Continuing Operations Ann.
-
-
-18-22.4-8.1-13.3-62.4-39.1-29.8-25.6-13.3-
Normalized EBITDA Ann.
-
-
-19.2-23.5-7.6-12.1-38.2-37.9-28.7-25.3-10.7-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
13.9%
2Y CAGR
61.3%
Operating Exp. Ann.
1Y CHG
-52.2%
2Y CAGR
-31.7%
3Y CAGR
-24.5%
5Y CAGR
-4.4%
7Y CAGR
15.5%
Operating Expenses Annual Cr is falling faster than historical averages.

Equillium Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Equillium Inc Dec-2025 Total Shareholders Fund is $29 Million which is growth of 50.0% YoY.

  • POSITIVE

    Total Assets Equillium Inc Dec-2025 Total Assets is $32 Million which is growth of 24.5% YoY.

Equillium Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-25.9%
-17.9%
31.925.650.578.485.485.455.567.27.2
⌄
-58.6%
-26.7%
3.36.52846.518.915.613.72.29.4
⌄
-3.6%
-16.4%
28.619.122.631.966.569.941.964.9-2.3
Total Capitalization Ann.
-6.7%
-18.2%
28.619.122.635.275.378.151.564.95.8
Tangible Assets Ann.
-3.6%
-16.4%
28.619.122.631.966.569.941.964.9-2.3
Working Capital Ann.
-14.3%
-18.4%
28.118.621.844.774.577.951.665.16.6
Invested Capital Ann.
-11.2%
-18.6%
28.619.122.640.976.779.851.564.95.8
Tangible Book Value Ann.
-3.6%
-16.4%
28.619.122.631.966.569.941.964.9-2.3
Borrowings Ann.
-59.1%
-41.1%
0.70.40.810.211.89.99.7-8.1
Net Debt Ann.
-
-
--------1
Share Issued Ann.
21.4%
19.9%
61.535.635.334.429.524.817.417.416.7
Number Of Shares End
21.4%
19.9%
61.535.535.234.429.424.817.417.411.7
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
24.6%
2Y CAGR
-20.5%
3Y CAGR
-25.9%
5Y CAGR
-17.9%
7Y CAGR
-10.1%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-54.7%
2Y CAGR
-67.6%
3Y CAGR
-55.1%
5Y CAGR
-16.6%
7Y CAGR
5.5%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
49.7%
2Y CAGR
12.5%
3Y CAGR
-3.6%
5Y CAGR
-16.4%
7Y CAGR
-11%
Total ShareHolders Funds Annual growth is higher than historical averages.

Equillium Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Equillium Inc Book Value Per Share is $1 which is growth of 939.3% YoY.

  • NEUTRAL

    ROE Equillium Inc ROE is 0% which is growth of 0% YoY.

Equillium Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
RoA Ann. %
-
-
--21.19%-20.68%-76.21%-45.72%-42.30%-41.73%-35.66%-
ROE Ann. %
-
-
--38.75%-48.92%-126.83%-57.28%-53.38%-47.95%-42.28%-
ROIC %
-
-
--27.8-11.46.9-12.6-10.4-13.8-18.5-
OPM Ann. %
-
-
--20.12%-40.24%-247.65%-----
Inventory Turnover Ratio Ann.
-
-
---------
Asset Turnover Ann. %
-
-
-1.10.60.2-----
Working Capital Turnover Ann.
-
-
2.21.70.4-
Quick Ratio Ann.
-
-
-3.71.72.39.111.313.732.512.5
Current Ratio Ann.
-
-
-3.91.82.49.411.814.333.112.6
Interest Coverage Ratio Ann.
-
-
---25-58.3-35.4-26.1-90.8-4.2-
LT Debt To Equity Ann.
-
-
-000.10.20.10.2--
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Equillium Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Equillium Inc Cash From Operating Activity is $-23 Million which is growth of -19.6% YoY.

  • POSITIVE

    Net Cash Flow Equillium Inc Net Cash Flow is $12 Million which is growth of 340.6% YoY.

Equillium Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-
-
-22.8-19-21.8-8.7-32.1-24.6-23-7.5-
⌄
-37.8%
-
4.513.8-4.818.727.4-18.6-2.2-37.4-
⌄
-
-10.8%
30.40.2-9.2-1.231.153.99.866.4-
Cash Plus Cash Eqv. End Of Year Ann.
-20%
4.8%
30.318.123.259.150.42413.228.5-
Net Increase In Cash Plus Cash Eqv.s Ann.
11.6%
2.5%
12.1-5.1-35.88.726.410.7-15.321.4-
Cash Plus Cash Eqv. Begin Of Year Ann.
-28.9%
6.5%
18.123.259.150.42413.228.57.1-
Income Tax Paid Supplemental Data Ann.
-
-
-0.6------
Interest Paid Supplemental Data Ann.
-
-
-10.90.80.80.1--
Capex Ann.
-
-
-0.1-0.1-0.1-0.3-0.1-0.2-0.1-0-
Issuance Of Capital Stock Ann.
-
-58%
0.7--29.953.864.5-
Issuance Of Debt Ann.
-
-
-----9.91.6-
Repayment Of Debt Ann.
-
-
--9.1-1.4-----
Repurchase Of Capital Stock Ann.
-
-
--0.3----0.2--
Free Cash Flow Ann.
-
-
-22.8-19.1-21.8-9-32.1-24.8-23-7.6-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Investing Act. Ann.
1Y CHG
-67.4%
3Y CAGR
-37.8%
Cash from Investing Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
1Y CHG
15100%
5Y CAGR
-10.8%
7Y CAGR
-10.6%
Cash from Financing Annual Activity growth is higher than historical averages.
×